SCHEMBL13487176

SCHEMBL13487176

CC1(C)c2ccccc2-c2c(-c3c4ccccc4c(-c4cnccn4)c4ccc(-c5cccc6ccccc56)cc34)cccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.34
FEN1 P39748 2/20 0.34
TNF P01375 1/20 0.33
HTR2C P28335 1/20 0.33
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CCNT1 O60563 1/20 0.32
CCNA2 P20248 1/20 0.32
CDK2 P24941 1/20 0.32
CDK9 P50750 1/20 0.32
ENPP3 O14638 1/20 0.32
ENPP1 P22413 1/20 0.32
GSK3B P49841 1/20 0.32
CDK5 Q00535 1/20 0.32
CDK5R1 Q15078 1/20 0.32
BACE1 P56817 1/20 0.32
KDM4E B2RXH2 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
TLR8 Q9NR97 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487278 0.91 SIRT2 (0.37) ALOX5APFEN1KDM4EPDK2SLC6A2
SCHEMBL13487982 0.90 ALOX5AP (0.36) ALOX5APFEN1TNFHTR2CMAPT
SCHEMBL13487356 0.90 ALOX5AP (0.35) ALOX5APFEN1PDK2SLC6A2SLC6A4
SCHEMBL13487110 0.90 PDK2 (0.35) ALOX5APFEN1BACE1PIK3CDPDK2
SCHEMBL13487170 0.90 HTR2C (0.42) HTR2CMAPTCCNT1CCNA2CDK2
SCHEMBL13487601 0.89 ALOX5AP (0.34) ALOX5APFEN1TNFHTR2CMAPT
SCHEMBL13487177 0.88 ENPP1 (0.33) TNFHTR2CMAPTCCNT1CCNA2
SCHEMBL13487172 0.86 PDK2 (0.41) TNFMAPTKMT2AKDM4EALDH1A1
SCHEMBL13487042 0.85 CYP3A4 (0.35) ALOX5APFEN1ALDH1A1HPGDPDK2
SCHEMBL13487174 0.84 MAPK11 (0.38) TNFMAPTENPP3ENPP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 ALOX5AP 230/4885FEN1 1389/4885TNF 1949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.